Delivery Order SPE2DB22D2206-SPE2DB25FEZ79

Award Date 1/7/25
Potential Completion Date 1/29/25
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,937.86 firm fixed-price delivery order is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award, valued at $78,951.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,052.93 firm fixed-price delivery order is for the supply of OPDIVO 240 MG/24 ML vials. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,689.30 firm-fixed-price delivery order is for the provision of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty medication, to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,813.58 firm fixed-price delivery order is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty pharmaceutical product, with a period of performance through January 2025. The contract award is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award is a delivery order worth $47,470.20 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty medication. The contract has an ultimate completion date of December 23, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award, valued at $31,646.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that the company holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of OPDIVO 240 mg/24 ml vials. The contract, valued at $15,294.80, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a key customer of AmerisourceBergen's federal contracting activities. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for the supply of a...
The federal contract award provides detailed information about a delivery order valued at $31,646.80 issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty oncology medication, with a period of performance through December 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,823.40 Firm Fixed Price Delivery Order covers the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialized pharmaceutical product. The contract has an ultimate completion date of December 26, 2024 and was awarded on December 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEZ79
    Delivery Order

This federal contract award, valued at $49,689.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty pharmaceutical product.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/8/25, 9:53 AM